(Q35196338)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909304%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909304%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909304%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

T L Sørensen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909304%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909304%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

published in

Brain Research Bulletin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909304%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909304%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909304%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

347-355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909304%20AND%20SRC:MED&resulttype=core&format=json

Pathology of multiple sclerosis: progression of the lesion

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Inflammatory vasculitis in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Cerebrospinal fluid activity of tissue plasminogen activator in patients with neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Tissue plasminogen activator gene expression in multiple sclerosis brain tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Chemokines in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Chemokines in the CNS: plurifunctional mediators in diverse states

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Human chemokines: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

The CCR5 deletion mutation fails to protect against multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Matrix metalloproteases: variations on a theme

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Lymphocyte homing and homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Matrix metalloproteinases degrade myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Chronologic localization of myelin-reactive cells in the lesions of relapsing EAE: implications for the study of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Enhanced endothelial cell adhesion of human cerebrospinal fluid lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Adhesion molecule phenotype of T lymphocytes in inflamed CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Immunological and neuropathological significance of the Virchow-Robin space

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Nervous tissue as an immune compartment: the dialect of the immune response in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Distinct roles for matrix metalloproteinase-2 and alpha4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

The significance of perivascular infiltrations in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

In vivo labeling of blood T cells: rapid traffic into cerebrospinal fluid in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Migration of Hematogenous Cells Through the Blood-Brain Barrier and the Initiation of CNS Inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

T-lymphocyte entry into the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1b

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Heterotrimeric G protein signaling: roles in immune function and fine-tuning by RGS proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Role of chemokines in the regulation of Th1/Th2 and autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

No evidence for elevated numbers of mononuclear cells expressing MCP-1 and RANTES mRNA in blood and CSF in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Physiology and immunology of lymphatic drainage of interstitial and cerebrospinal fluid from the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Chemokines and chemotaxis of leukocytes in infectious meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

The inflammatory lesion of T cell line transferred experimental autoimmune encephalomyelitis of the Lewis rat: distinct nature of parenchymal and perivascular infiltrates

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Extracellular matrix degradation by metalloproteinases and central nervous system diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Immunopathogenesis of multiple sclerosis: the role of T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Inflammation in the CNS: balance between immunological privilege and immune responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Macrophage inflammatory protein-1 alpha in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

The molecular biology of leukocyte chemoattractant receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Leukotrienes in the cerebrospinal fluid of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

1 reference

7 January 2021

Metalloproteinases and their tissue inhibitors in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Bradykinin B1 receptor expression and function on T lymphocytes in active multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Leukocyte Gelatinase B Cleavage Releases Encephalitogens from Human Myelin Basic Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

The strategy of blocking the chemokine system to combat disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Treatment of murine experimental autoimmune encephalomyelitis with a myelin basic protein peptide analog alters the cellular composition of leukocytes infiltrating the cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

The role of chemokine receptors in primary, effector, and memory immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Intrathecal activation of the complement system and disability in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

HLA DRB1*1501 and intrathecal inflammation in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

The subarachnoid space as a site for precursor T cell proliferation and effector T cell selection in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Homing of T cells to the central nervous system throughout the course of relapsing experimental autoimmune encephalomyelitis in Thy-1 congenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Etiology and pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Distinct chemokine receptor and cytokine expression profile in secondary progressive MS

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Increased numbers of CCR5+ interferon-gamma- and tumor necrosis factor-alpha-secreting T lymphocytes in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Role of chemokines, neuronal projections, and the blood-brain barrier in the enhancement of cerebral EAE following focal brain damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Fluids of the brain and the pathogenesis of MS

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

T-Cell Function and Migration — Two Sides of the Same Coin

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Interferon beta in the treatment of multiple sclerosis: mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Matrix metalloproteinases and diseases of the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Aberrant T cell migration toward RANTES and MIP-1 alpha in patients with multiple sclerosis. Overexpression of chemokine receptor CCR5.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Cutting edge: differential expression of chemokines in Th1 and Th2 cells is dependent on Stat6 but not Stat4

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Induction of metalloproteinase activity in human T-lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

Chemokines: a new classification system and their role in immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900097-2

7 January 2021

10.1016/S0361-9230(03)00097-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909304%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference